Clinical Performance of Advanced Self- Adhesivee Resin Composite Hybrid Restorations.

Sponsor
Rawda Hesham Abd ElAziz (Other)
Overall Status
Recruiting
CT.gov ID
NCT04790383
Collaborator
(none)
63
1
2
12.9
4.9

Study Details

Study Description

Brief Summary

Clinical performance according to modified USPHS criteria of advanced self-Adhesive resin composite hybrid restorations is evaluated for 1 year versus conventional resin composite restorations in posterior teeth.

Condition or Disease Intervention/Treatment Phase
  • Other: Advanced Self-Adhesive resin composite hybrid restorations (Surefil one (Dentsply Sirona)).
  • Other: Conventional resin composite restoration. (Sphere Tec, (Dentsply Sirona
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
63 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Clinical Performance of Advanced Self-Adhesive Resin Composite Hybrid Restorations Versus Conventional Resin Composite Restorations in Posterior Teeth (1y Randomized Clinical Trial).
Actual Study Start Date :
Feb 1, 2021
Anticipated Primary Completion Date :
Feb 1, 2022
Anticipated Study Completion Date :
Mar 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Advanced Self-Adhesive resin composite hybrid restorations

(Surefil one (Dentsply Sirona)).

Other: Advanced Self-Adhesive resin composite hybrid restorations (Surefil one (Dentsply Sirona)).
Hybrid resin composite that doesn't need bonding system and releases calcium and flouride.

Active Comparator: Conventional resin composite restoration.

Sphere Tec, (Dentsply Sirona)

Other: Conventional resin composite restoration. (Sphere Tec, (Dentsply Sirona
Conventional Nanohybrid resin composite

Outcome Measures

Primary Outcome Measures

  1. Clinical performance [Change from baseline at 6, 12 months]

    Post operative Hypersensitivity, Secondary caries, Gross fracture, Cavo-surface marginal discoloration, Proximal contact. All these outcomes are measured by a score Alpha is excellent, Bravo is acceptable, Charlie is not accepted

Eligibility Criteria

Criteria

Ages Eligible for Study:
17 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients with carious proximal cavities in molars

  • Good oral hygiene.

  • Presence of favorable occlusion and teeth are in normal contact with the adjacent teeth.

Exclusion Criteria:
  • Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis.

  • Severe periodontal problems.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cairo University Cairo Egypt

Sponsors and Collaborators

  • Rawda Hesham Abd ElAziz

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Rawda Hesham Abd ElAziz, lecturer at Conservative Dentistry department, Cairo University
ClinicalTrials.gov Identifier:
NCT04790383
Other Study ID Numbers:
  • CU-2-2021
First Posted:
Mar 10, 2021
Last Update Posted:
Mar 10, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rawda Hesham Abd ElAziz, lecturer at Conservative Dentistry department, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 10, 2021